Jeffrey Himmel is an experienced CEO who joined ChromaDex Corporation on January 23, 2012. He previously led The Himmel Group, where he successfully grew brands like GOLD BOND MEDICATED POWDER and OVALTINE, significantly increasing their market success. Jeffrey has a...

Jeffrey Himmel is an experienced CEO who joined ChromaDex Corporation on January 23, 2012. He previously led The Himmel Group, where he successfully grew brands like GOLD BOND MEDICATED POWDER and OVALTINE, significantly increasing their market success. Jeffrey has a solid educational background, holding a Bachelor of Science in Economics from the Wharton School and a Master of Science in Taxation from Bentley College. His expertise lies in marketing and consumer goods, which is essential for driving ChromaDex’s growth in the nutritional industry. In his role at ChromaDex, he received a base salary of $360,000 but had potential bonuses tied to the company’s performance. Interestingly, Jeffrey was also involved with the Consumer Healthcare Products Association for decades and even served on the board of Wharton’s Undergraduate Executive Board. With a track record of turning small brands into market leaders, he seems to have a keen instinct for identifying growth opportunities. Overall, his leadership is expected to bring significant insights to ChromaDex as it expands its footprint.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other ChromaDex CEOs

C

Jeffrey Himmel

Ex-CEO of ChromaDex

Education

B.S. in Economics from the Wharton School of Finance and Commerce at the University of Pennsylvania, Master of Science in Taxation from Bentley College

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of ChromaDex for

6 years 4 months (Jan 2012 - Jun 2018)

Previous Experience

Former Chairman of The Himmel Group

Rivals

Competitors/colleagues of Jeffrey Himmel

Holdings

See how much did Jeffrey Himmel make over time.

Jeffrey Himmel held 100,000 shares of restricted common stock in ChromaDex when he became CEO. This stock was part of his employment agreement and was fully vested upon issuance. However, during his brief tenure, the stock's market performance was likely...

Jeffrey Himmel held 100,000 shares of restricted common stock in ChromaDex when he became CEO. This stock was part of his employment agreement and was fully vested upon issuance. However, during his brief tenure, the stock's market performance was likely concerning as it’s common for such companies to experience volatility. At one point, he had other options and stock awards that were contingent on performance metrics and would provide him with upward financial mobility if company targets were met. Unfortunately, after stepping down on June 11, 2012, Himmel forfeited many of these, including his stock options, and retained only the 100,000 shares of common stock, which could pose a risk if market conditions were unfavorable. By the time of his departure, his holdings reflected a significant investment in the company, signaling his commitment to its success.

Loading...

Insider Trading

See recent insider trades of Jeffrey Himmel.

No insider trades found for this CEO.

Compensation History

See how much did Jeffrey Himmel make over time.

In 2012, Jeffrey Himmel's total compensation as CEO of ChromaDex was primarily salary-based, amounting to $360,000. His agreement included potential increases and a $50,000 bonus if the company met certain stock listing criteria. However, he did not receive additional bonuses that year after joining, nor did any stock options vest at that time. His contract also allowed for significant potential bonuses based on company performance metrics, which could top 300% of his salary if targets were substantially exceeded. Ultimately, his arrangement was structured to emphasize performance, aligning his activities with the company's goals. If he had met these benchmarks, his compensation could have significantly increased, showcasing a strong incentive structure designed to encourage growth.

Year

2012

Total Compensation

$225.00K

Salary

$225.00K

Board Justification

The company aims to attract and retain executive talent through competitive compensation packages that align with performance and market standards.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2012.

Other

$0.00

Board Justification

No other compensation was specified for the year 2012.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2012 as the stock grants were not specified in the provided proxy statement.

Performance Metrics

Performance metrics were not specified in the provided proxy statement.

Other ChromaDex CEOs

Here are other CEOs of ChromaDex

Frank L. Jaksch, Jr.

Ex-CEO of ChromaDex

April 2010 - January 2012

Robert Fried

CEO of ChromaDex

June 2018 - Present